M Heinzelmann1, M Mercer-Jones, W G Cheadle, H C Polk. 1. Price Institute of Surgical Research, Department of Surgery, University of Louisville, School of Medicine, Kentucky 40292, USA.
Abstract
OBJECTIVE: The authors determined the correlation between monocyte CD14 expression and outcome in severely injured patients. SUMMARY BACKGROUND DATA: Human leukocyte antigen-DR (HLA-DR) expression CD14 positive monocytes correlates with the development of major infection and subsequent death in severely injured patients. Recent studies show that CD14 is not only a marker for mature monocytes, but also is an important endotoxin/lipopolysaccharide receptor. METHODS: Flow cytometry data obtained by dual staining techniques (CD14 and HLA-DR) of monocytes in 213 severely injured patients were analyzed over a 30-day period. Outcome criteria included survival and the development of both major and minor infections. RESULTS: The percentage of cells expressing CD14 (%CD14) correlated with clinical outcome, reaching significance (p < 0.05) between noninfected survivors (n = 74) and nonsurvivors (n = 21) at days 3, 7, 11, 17, 24, and 30. At days 3, 7, and 17, the %CD14 also was different between noninfected and infected survivors. After 7 days, differences were only seen between survivors and nonsurvivors (p < 0.05). The mean fluorescence intensity (MC CD14) in monocytes of all patients was significantly reduced at day 3 compared with day 1 and remained low for 30 days (p < 0.05). The nonsurvivor group had consistently low MC CD14 values, which were significant at day 5 (p < 0.05). CONCLUSIONS: In addition to HLA-DR expression, CD14 expression on monocytes is an indicator of clinical outcome after injury and could represent a more precise target for treatment.
RCT Entities:
OBJECTIVE: The authors determined the correlation between monocyte CD14 expression and outcome in severely injured patients. SUMMARY BACKGROUND DATA: Human leukocyte antigen-DR (HLA-DR) expression CD14 positive monocytes correlates with the development of major infection and subsequent death in severely injured patients. Recent studies show that CD14 is not only a marker for mature monocytes, but also is an important endotoxin/lipopolysaccharide receptor. METHODS: Flow cytometry data obtained by dual staining techniques (CD14 and HLA-DR) of monocytes in 213 severely injured patients were analyzed over a 30-day period. Outcome criteria included survival and the development of both major and minor infections. RESULTS: The percentage of cells expressing CD14 (%CD14) correlated with clinical outcome, reaching significance (p < 0.05) between noninfected survivors (n = 74) and nonsurvivors (n = 21) at days 3, 7, 11, 17, 24, and 30. At days 3, 7, and 17, the %CD14 also was different between noninfected and infected survivors. After 7 days, differences were only seen between survivors and nonsurvivors (p < 0.05). The mean fluorescence intensity (MC CD14) in monocytes of all patients was significantly reduced at day 3 compared with day 1 and remained low for 30 days (p < 0.05). The nonsurvivor group had consistently low MC CD14 values, which were significant at day 5 (p < 0.05). CONCLUSIONS: In addition to HLA-DR expression, CD14 expression on monocytes is an indicator of clinical outcome after injury and could represent a more precise target for treatment.
Authors: F Kanakoudi-Tsakalidou; F Debonera; V Drossou-Agakidou; K Sarafidis; V Tzimouli; A Taparkou; G Kremenopoulos Journal: Clin Exp Immunol Date: 2001-03 Impact factor: 4.330
Authors: Jose M Prince; Ryan M Levy; John Bartels; Arie Baratt; John M Kane; Claudio Lagoa; Jonathan Rubin; Judy Day; Joyce Wei; Mitchell P Fink; Sanna M Goyert; Gilles Clermont; Timothy R Billiar; Yoram Vodovotz Journal: Mol Med Date: 2006 Apr-Jun Impact factor: 6.354
Authors: N Hiki; D Berger; C Prigl; E Boelke; H Wiedeck; M Seidelmann; L Staib; M Kaminishi; T Oohara; H G Beger Journal: Infect Immun Date: 1998-03 Impact factor: 3.441
Authors: M Ditschkowski; E Kreuzfelder; V Rebmann; S Ferencik; M Majetschak; E N Schmid; U Obertacke; H Hirche; U F Schade; H Grosse-Wilde Journal: Ann Surg Date: 1999-02 Impact factor: 12.969
Authors: J Perren Cobb; Ernest E Moore; Doug L Hayden; Joseph P Minei; Joseph Cuschieri; Jingyun Yang; Qing Li; Nan Lin; Bernard H Brownstein; Laura Hennessy; Philip H Mason; William S Schierding; David J Dixon; Ronald G Tompkins; H Shaw Warren; David A Schoenfeld; Ronald V Maier Journal: Ann Surg Date: 2009-10 Impact factor: 12.969
Authors: Pedro V da Silva-Neto; Jonatan C S de Carvalho; Vinícius E Pimentel; Malena M Pérez; Diana M Toro; Thais F C Fraga-Silva; Carlos A Fuzo; Camilla N S Oliveira; Lilian C Rodrigues; Jamille G M Argolo; Ingryd Carmona-Garcia; Nicola T Neto; Camila O S Souza; Talita M Fernandes; Victor A F Bastos; Augusto M Degiovani; Leticia F Constant; Fátima M Ostini; Marley R Feitosa; Rogerio S Parra; Fernando C Vilar; Gilberto G Gaspar; José J R da Rocha; Omar Feres; Fabiani G Frantz; Raquel F Gerlach; Sandra R Maruyama; Elisa M S Russo; Angelina L Viana; Ana P M Fernandes; Isabel K F M Santos; Vânia L D Bonato; Antonio L Boechat; Adriana Malheiro; Ruxana T Sadikot; Marcelo Dias-Baruffi; Cristina R B Cardoso; Lúcia H Faccioli; Carlos A Sorgi Journal: Viruses Date: 2021-12-15 Impact factor: 5.048